Philips Archives - Page 15 of 19 - Medical Design Sourcing

Philips treats first patient will 3D intracardiac echocardiography catheter

Royal Philips (NYSE:PHG) announced today that it treated the first patient with its real-time, 3D intracardiac echocardiography (ICE) catheter.

Dr. Mohamad Adnan Alkhouli performed a left atrial appendage occlusion (LAAO) procedure with Philips’ VeriSight Pro platform at the Minneapolis-based Mayo Clinic.

The real-time 3D Philips intracardiac echocardiography catheter, when combined with Philips’ premium cardiology ultrasound system (EPIQ CVx), offers 2D and 3D live image guidance for a wide range of procedures for structural heart disease and electrophysiology, according to a news release.

VeriSight Pro uses the same ultrasound technology used in standard live ultrasound imaging for heart disease and electrophysiology but miniaturized to fit on the tip of a 1.98 mm-diameter catheter that can be navigated to the patient’s heart through their vasculature. The procedure does not require general anesthesia.

The platform is available…

Philips seeks to reduce MRI evaluation of the heart down to a few minutes

[Image from Philips]Royal Philips (NYSE:PHG) announced today that it’s part of a research project for developing a change in MRI imaging in cardiology.

Amsterdam-based Philips is collaborating with the Spanish National Center for Cardiovascular Research (CNIC) to research a new technique to bring ultra-fast, easy cardiac magnetic resonance (MR) imaging to clinical settings in a way that benefits more patients.

Get the full story at our sister site, Medical Design & Outsourcing.

Philips seeks to reduce MRI evaluation of the heart down to a few minutes

[Image from Philips]

Royal Philips (NYSE:PHG) announced today that it’s part of a research project for developing a change in MRI imaging in cardiology.

Amsterdam-based Philips is collaborating with the Spanish National Center for Cardiovascular Research (CNIC) to research a new technique to bring ultra-fast, easy cardiac magnetic resonance (MR) imaging to clinical settings in a way that benefits more patients.

The Carlos III Institute of Health, through a FIS technological development project, provided funds for the project, along with a Translational Research Grant from the Spanish Society of Cardiology, the European Research Council (ERC), and the Community of Madrid, according to a news release.

With this new technique — called ‘Enhanced SENSE by Static Outer-volume Subtraction (ESSOS) — the MRI signal of the beating heart can be more easily subtracted from subsequent scan data, thanks t…

MedTech 100 roundup: Nearing new highs once again

Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set one week prior (June 18). In all, the industry has risen 5.9% over the past three weeks.

The recent upswing shows no signs of slowing after the industry’s progress came to a halt with a -1.4% dip earlier this month. The index looks set to close in on the 114.58-point mark set in April, marking the industry’s all-time best performance.

Even with some recent setbacks, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 22.9% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus a 82.6% increase from the mid-pandemic low …

Philips CPAP recall could be an opportunity for ResMed, analysts say

Baird analysts say that the recall of certain sleep and respiratory devices by Royal Philips (NYSE:PHG) may benefit ResMed (NYSE:RMD).

Earlier this month, Amsterdam-based Philips provided an update on the April 26 recall for some bi-level PAP and CPAP ventilator devices with a foam component problem, with the company expecting revenue headwinds in its sleep and respiratory care business to be compensated by the performances of its other businesses. It elected not to change financial guidances provided with the initial recall announcement.

Analysts at Baird, however, noted that there is an opportunity for ResMed to get a jump on Philips amid the recall with its respiratory products, although there is a high degree of difficulty as far “meaningfully capitalizing on this disruption,” and few clear answers exist right now.

ResMed, one of the top-performing stocks of 2020, saw a 4.6% rise from market open to market close on June 14, the day Philip…

Philips issues recall for foam component in some sleep and respiratory care devices

Royal Philips (NYSE:PHG) today provided an update on the recall for specific bi-level PAP and CPAP ventilator devices.

On April 26, Philips issued a recall notification for specific Philips bi-level positive airway pressure (bi-level PAP), continuous positive airway pressure (CPAP) and mechanical ventilator devices due to potential risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component in the devices.

According to a news release, the majority of the affected devices within the advised five-year service life are in the first-generation DreamStation product family. The complaint rate registered at 0.03% in 2020, Philips said.

The Amsterdam-based company determined through testing that there are possible risks to users related to the PE-PUR sound abatement foam component, including the possibility of the foam degrading into particles that may enter the device’s air pathway and be ingested by the user.

Addition…

Philips touts 2-year data for Tack endovascular system

[Image from Philips]Royal Philips (NYSE:PHG) today announced positive two-year results from a clinical trial of the Tack endovascular system.

Amsterdam-based Philips presented data from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial at the 2021 New Cardiovascular Horizons Conference, according to a news release.

Data presented by co-principal investigator Dr. George Adams, an interventional cardiologist at Rex Hospital (University of North Carolina, Chapel Hill) demonstrated a sustained treatment effect and a positive impact on quality of life for patients with peripheral artery disease (PAD) and critical limb ischemia (CLI) treated with the Tack dissection repair device, which Philips acquired when it bought Intact Vascular for $275 million in August 2020.

Tack, a specialized, implantable device designed to optimize the treatment of dissections in patients with PAD and CLI, provided 73.6% of patients freedom from clini…

Philips’ trade secret suit against Chinese companies can proceed

A federal judge has ruled that two companies in China and a U.S. company must face a trade secrets lawsuit by Philips.

Philips claims that two former employees who joined GL Leading, an Aurora, Ill.-based firm allegedly formed from a pair of related companies in China, stole proprietary information about certain Philips’ X-ray tubes. Philips is also suing those former employees, Jose Buan and Sherman Jen, as well as the Chinese companies, Kunshan Yiyuan Medical Technology and Kunshan Guoli Electronic Technology,

Philips alleges that in late December 2017, Buan copied more than 800 of Philips’ files, “including trade secret and other confidential business information” onto portable drives, according to the order by Judge Marvin E. Aspen.

“A subsequent investigation revealed that Buan took ‘a trove’ of additional files containing ‘confidential and trade secret technical and business information pertaining to the 2XXX series X…

FDA clears Philips’ Smart CT application software

[Image from Philips]Royal Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its Philips SmartCT application software.

Amsterdam-based Philips’ SmartCT software is a component of the company’s Azurion image-guided therapy system for diagnosis, therapy planning, treatment and follow-up for interventional radiology procedures.

SmartCT helps to enhance clinical confidence, smooth the workflow and increase productivity through software applications for angiography, neurology, soft-tissue imaging and guidewire/catheter navigation for procedures that treat aneurysms, vascular disease and liver tumors, among others, according to a news release.

The platform enables control of the Azurion system on a touchscreen tablet situated alongside the interventional radiology table, eliminating the need for clinicians to leave the sterile field and step into an adjacent control room while also supporting faster and better-informed decisi…

How 5G could affect medtech

The latest standard of broadband technology continues to make waves in 2021. But what about medtech?

Cellphone using 5G

Cellphone using 5G (Imagy by Frederik Lipfert on Unsplash)

Wireless tech companies such as Qualcomm are predicting download speeds as high as 10 gigabits per second as next-generation 5G cellular networks roll out worldwide.

The open question in medtech is how quickly companies will take advantage of the super-speedy connectivity for their own products.

“5G is about bringing more capacity and speed to the pipes,” said Don Jones, a member of the advisory council at BrightInsight and a veteran of the digital healthcare space. Jones spent more than 11 years building Qualcomm’s healthcare group.

“What you have to analyze is, ‘Can healthcare take advantage of what essentially amounts to these bigger pipes?’ Because more data can be shoved through them with m…

How big medtech fared during a year of COVID-19

[Image from Unsplash]Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials.

Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against the COVID-19 pandemic. Employment was also up slightly amongst the top earners, while R&D spending held its own.

The 20 companies included in the MDO analysis include 3M Healthcare, Abbott (medical device segment), Alcon, Align Technology, Baxter, Boston Scientific, Danaher (life sciences and diagnostics segment), Dentsply Sirona, Edwards Lifesciences, GE Healthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson (medical device segment), Medline Industries, Owens & Minor, Royal Philips, Smith+Nephew, Stryker, Teleflex and Zimmer Biomet.

Get the full s…

Philips debuts AI-enhanced imaging platform

Royal Philips (NYSE:PHG) today said it launched its AI-enabled Precise Suite for its Incisive CT platform.

The Precise Suite delivers smart workflows from image acquisition through reporting with AI-enabled image reconstruction, automated patient positioning, motion-free cardiac image capture and real-time interventional guidance, according to the company. The artificial intelligence helps streamline and automate workflows to maximize image quality and reduce the number of re-scans needed to improve diagnostic confidence.

“With CT representing one of the most ubiquitous imaging modalities in modern medicine, AI-enabled enhancements such as Precise Suite that focus on diagnostic confidence and workflow improvement have huge potential to make a positive impact on the delivery of value-based healthcare,” GM of computed tomography Karim Boussebaa said in a news release. “Precise Suite drives end-to-end smart workflows from image acquisition through to reporting, as…